The goal of this clinical trial is to learn if a shared decision-making tool called SHARE-HF can help more people with heart failure receive guideline-recommended medications. The study includes adults with a type of heart failure called heart failure with reduced ejection fraction (HFrEF), who attend heart function clinics in British Columbia, Canada. The main question it aims to answer is: \- Does use of SHARE-HF during clinic visits lead to more participants receiving their recommended heart failure medications after 6 months? Researchers will compare clinics using the SHARE-HF tool to clinics providing usual care to see if the tool helps more participants get their recommended medications. Participants will use the SHARE-HF web-based tool with their clinician during regular clinic visits. The tool shows participants how their heart failure may affect their health over time, explains their medication options, and helps them and their clinician make treatment decisions together.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
1,350
Web-based, interactive decision aid that: (1) provides individualized prognosis based on a validated clinical prediction model; (2) presents evidence-based medication options aligned with guidelines; and (3) quantifies benefits and downsides across six patient-prioritized features.
Efficacy-weighted HFrEF guideline-directed medical therapy (GDMT) score
Scores range from 0 to 8, with a higher score indicating greater (better) GDMT utilization.
Time frame: 6 months
Worsening heart failure events
Time frame: 1 year; 3 years
Adherence to HFrEF GDMT
Time frame: 1 year; 3 years
Average percent concordance between prescribed and dispensed prescriptions for GDMT
Time frame: 1 year
Utilization of individual HFrEF medication classes at any dose
Time frame: Months 3, 6, and 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.